Clinical Trial

Lactose Intolerance and Intestinal Permability

Study acronym: LI
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
"This study evaluates the interplay between lactose intolerance, intestinal barrier function (zonulin), and intestinal inflammation (fecal calprotectin) in adults, aiming to clarify their independent contributions to symptom severity and quality of life."
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-16.
Trial Details
NCT Number NCT07424898
Lead Sponsor Bezmialem Vakif University
Conditions Lactose Intolerance, Adult Type, Intestinal Permability, IBS (Irritable Bowel Syndrome)
Enrollment 200 participants
Start Date 2026-02-10
Primary Completion 2026-12-15 (estimated)
Study Completion 2027-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-25